Financhill
Back

Akero Therapeutics Vs. TransMedics Group Industry Stock Comparison

Sell
28

AKRO
Akero Therapeutics

Last Price:
$28.90
Seasonality Move:
-9.11%
Sell
38

TMDX
TransMedics Group

Last Price:
$62.59
Seasonality Move:
22.15%
Sell
28
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $28.56. The Score for AKRO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
TransMedics Group (TMDX) is a Sell

Is TransMedics Group a Buy, Sell or Hold?

  • The current TransMedics Group [TMDX] share price is $63.90. The Score for TMDX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • TMDX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $28.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight buying pressure.

TMDX Stock Price Chart

What is TransMedics Group's stock price today?

  • The TransMedics Group share price today is $63.90
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TMDX is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.62 Sell
Relative Strength Index (14 RSI): 42.92 Sell
Chaikin Money Flow: 107245 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.15 - 31.69) Sell
Bollinger Bands (100): (26.14 - 31.32) Sell

TMDX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -7.37 Sell
Relative Strength Index (14 RSI): 35.01 Sell
Chaikin Money Flow: 420637 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.16 - 79.84) Sell
Bollinger Bands (100): (82.38 - 159.12) Sell

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.02 Sell
20-day SMA: 30.16 Sell
50-day SMA: 30.77 Sell
200-day SMA: 25.89 Buy
8-day EMA: 29.06 Sell
20-day EMA: 29.8 Sell
50-day EMA: 29.96 Sell
200-day EMA: 27.84 Buy

TMDX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 62.99 Buy
20-day SMA: 69.68 Sell
50-day SMA: 86.67 Sell
200-day SMA: 120.34 Sell
8-day EMA: 63.76 Buy
20-day EMA: 69.28 Sell
50-day EMA: 86.67 Sell
200-day EMA: 109.1 Sell

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.08 per share, and a decrease next year of $0.90 per share.

TransMedics Group Earnings Growth & TMDX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.53 per share, and an increase next year of $0.45 per share.

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

TransMedics Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):